BioImagery

BioImagery is an Israeli private healthcare company formed in 2020 as a joint venture associated with Todos Medical and Care G.B. Plus. The company appears to have been established to develop, market, and commercialize the cancer-related assets and intellectual property associated with Todos Medical’s Total Biochemical Infrared Analysis (TBIA) blood-based diagnostics platform, particularly in Israel, Europe, and Africa. Public disclosures describe BioImagery as supporting commercialization of AI-enabled, spectroscopy-based cancer detection products rather than developing therapeutic drugs. Available evidence indicates it is an active private company, but detailed standalone operating disclosures, product launches, and financial information remain limited. For a biotech analyst, BioImagery is best understood as a small diagnostics commercialization vehicle tied to Todos Medical’s early cancer detection platform rather than a traditional therapeutics biotech company.